Bristol-Myers Squibb Co (BMY) stock is down -0.73% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives BMY stock a score of 68 out of a possible 100. That rank is chiefly influenced by a long-term technical score of 88. BMY's rank also includes a short-term technical score of 62. The fundamental score for BMY is 55. In addition to the average rating from Wall Street analysts, BMY stock has a mean target price of $71.30. This means analysts expect the stock to increase 11.91% over the next 12 months.
BMY has an Overall Score of 68. Find out what this means to you and get the rest of the rankings on BMY!